Artificial Muscle Names Art Goldberg CEO and Chairman of the Board

Share Article

Seasoned executive tapped to help Artificial Muscle Inc. exploit multi-billion dollar electroactive polymer actuator market opportunity.

Artificial Muscle Inc., (AMI) a volume manufacturer that designs and builds linear actuator components based on its patented Electroactive Polymer Artificial Muscle (EPAM™) technology is pleased to announce the appointment of Art Goldberg as President, Chief Executive Officer and Chairman of the Board of Directors. Charlie Duncheon, who had been serving as interim CEO has been named Executive Vice President of Marketing and Sales and Secretary of the Board of Directors. Further information is available at the Artificial Muscle website,

“Artificial Muscle’s EPAM technology is the most exciting opportunity I have seen in the last 15 years,” said Mr. Goldberg. “It is capable of replacing almost any actuator mechanism with a smaller, lighter, more efficient and less expensive artificial muscle-based actuator based on AMI’s EPAM technology. Linear actuators are ubiquitous components in products that include movement- everything from automobiles to medical devices. Enabling a new generation of actuators with no mechanical moving parts represents an opportunity in excess of twenty-five billion dollars annually for Artificial Muscle, one that we are poised to exploit over the next several years.”

Mr. Goldberg brings a long and proven track record of capitalizing on, and monetizing advanced technology. Prior to AMI, Mr. Goldberg served successfully in CEO, COO and other senior management roles at Pathscale (acquired by QLogic), Entegrity Solutions, Hal Computer Systems (acquired by Fujitsu) and Atherton Technology. Art spent twenty-four years at IBM in sales management, marketing, and product management. He was the Director of Development Operations on the RS/6000 and AIX, Director of Workstation Strategy, and the principal author of IBM's High Performance Computing Strategy.

“Art adds a wealth of strategic, operational, and financial expertise to Artificial Muscle’s all-star management team,” said Dan Eilers, General Partner of Vanguard Ventures, an investor in AMI. “We believe that Artificial Muscle will create an actuator technology revolution, and Art is exactly the right executive to lead it.”

Details and design guides for the EPAM technology are available at

About Artificial Muscle Inc.

Artificial Muscle Inc. is a technology company that designs and manufactures linear actuator and sensing components based on its patented technology platform called Electroactive Polymer Artificial Muscle (EPAM). EPAM technology is called artificial muscle because of the context of its historical development and because, much like human muscle, it converts one form of energy (electrical field energy) into mechanical motion. It offers significant advantages over typical electromagnetic-based technologies because it is much lighter, smaller, quieter and cheaper, and offers more controllable and flexible configurations. EPAM devices serve as lightweight, highly efficient alternatives to actuators, small motors, generators, sensors, and speakers used in products ranging from automobiles to audio speakers. AMI is serving a market that currently measures four billion dollars annually with artificial muscle-based components for industrial, medical, consumer, automotive, and aerospace applications.

AMI was founded by SRI International, a Silicon Valley non-profit research and development institute that has a fifty-year history of developing pioneering technologies. Artificial Muscle was spun-out of SRI to exclusively commercialize artificial muscle technology. AMI became an independent company in early 2004 with venture capital financing from Vanguard Ventures, ARCH Venture Partners, and NGEN Partners.

Contact Artificial Muscle Inc.:

Timothy E. Coogan

Tel: 650-331-2890

Fax: 650-331-2877

Electroactive Polymer Actuator Muscle and EPAM are trademarks of Artificial Muscle Inc.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tim Coogan
Visit website